Skip to main content

Table 11 Incidences of any DVT (up to POD10) and major bleeding (up to POD28) in propensity-matched fondaparinux- or enoxaparin-treated groups (TKA)

From: Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study

Events Fondaparinux Enoxaparin Risk ratio (95% CI) P value
n = 204 n = 204
DVT 28/204 (13.6%) 54/204 (26.2%) 0.70 (0.58-0.85) 0.002
Major bleeding 7/204 (3.4%) 1/204 (0.5%) 4.18 (0.67-26.20) 0.062
  1. CI, confidence interval; DVT, deep vein thrombosis; POD, postoperative day; TKA, total knee arthroplasty.